Welcome to the Nevada Opioid Center of Excellence
The Nevada Opioid Center of Excellence (NOCE) is dedicated to developing and sharing evidence-informed training and offering technical assistance to professionals and community members alike. Whether you are a care provider or a concerned community member, NOCE provides resources to support those affected by opioid use.
Click on any of our ‘Frequently Asked Questions’ by selecting it from the buttons below.
Request Technical Assistance (TA) from the Nevada Opioid Center of Excellence
Technical Assistance (TA) is about giving people, organizations, and programs the help they need to grow, improve, and reach their goals. This can include things like:
- Expert advice
- Training
- Helpful tools or resources
- Planning strategies
Who Can Request TA?
1
Submit Request
request form on
our website
2
Initial Contact
schedule a virtual
meeting.
3
Develop Plan
works for you.
4
Receive Support
training, and
resources.
5
Check-In
ensure your
support.
Request Technical Assistance (TA) from the Nevada Opioid Center of Excellence
Technical Assistance (TA) is about giving people, organizations, and programs the help they need to grow, improve, and reach their goals. This can include things like:
- Expert advice
- Training
- Helpful tools or resources
- Planning strategies
Who Can Request TA?
Upcoming Events
News Updates
Introducing the Nevada Office-Based Opioid Treatment (OBOT) Onboarding Toolkit
Starting Office-Based Opioid Treatment (OBOT) in Nevada can feel complex, but it doesn’t have to be. This toolkit provides a clear, step-by-step roadmap to help prescribers navigate requirements, establish services, and become ready to prescribe medications for opioid use disorder (MOUD) with confidence.
Nevada Overdose Data to Action: May 2026 Data Updates
The Nevada Overdose Data to Action (OD2A) team has released May updates, including new monthly surveillance reports and upcoming office hours for partners interested in overdose data. What is Overdose Data
Beyond Xylazine: The Dangerous Emergence of Medetomidine (“Rhino Tranq”)
The landscape of the United States illicit drug market is shifting with terrifying speed. For several years, public health officials have struggled to contain the “fourth wave” of the opioid crisis, characterized by the adulteration of fentanyl with the veterinary sedative xylazine, commonly known as “tranq.” However, just as harm reduction strategies began to adapt to xylazine, a more potent and dangerous additive has emerged: medetomidine.